ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
29722.1 IP-LS
Project title
Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Doktor
Vladimir Katanaev
Université de Genève
Rue Michel Servet 1
CH-1211 Genève
+41 22 3795353.
vladimir.katanaev@unige.ch